New York, New York (PRWEB) February 22, 2014
The federal court overseeing more than 1,000 Biomet hip lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) that allege injury due to the M2a Magnum Hip Replacement System has granted the parties’ Joint Stipulation to Stay Responsive Pleading Deadlines for all cases pending in the litigation. According to an Order issued in the U.S. District Court, Northern District of Indiana on February 14, 2014, the Stay will remain in effect until the parties agree that the obligations contemplated in the recently announced Biomet hip replacement settlement agreement have been met. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“Our Firm is representing a number of Biomet hip lawsuit clients who may be eligible to participate in the settlement program. We are pleased with the progress in this matter,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal consultations to M2a Magnum hip recipients who allegedly suffered serious and debilitating complications due to its metal-on-metal design.
Biomet Hip Replacement Lawsuit
According to court documents, 1,141 Biomet hip lawsuits are currently pending in the Northern District of Indiana. All of the lawsuits similarly allege that recipients of the metal-on-metal M2a Magnum hip system suffered metallosis, pseudotumor formation, early device failure and other serious complications due to its propensity to shed dangerous amounts of toxic metal ions into patients’ tissue and blood stream. On February 3, 2014, U.S. District Judge Robert L. Miller, Jr. approved the Biomet hip replacement settlement, which could resolve hundreds of claims filed in the proceeding.
To participate in the settlement program, plaintiffs must file their Biomet hip lawsuits no later than April 15, 2014. According to court documents, plaintiffs who received one of the affected Biomet hip replacements as part of an initial surgery that was rectified more than 180 days after it was implanted will be eligible for a base award of $200,000.
The Biomet M2a Magnum hip system is a metal-on-metal hip implant, a class of devices that is currently being reviewed by the U.S. Food & Drug Administration (FDA). In January 2013, the agency recommended that all-metal hip recipients undergo blood testing for elevated levels of metal ions if they experience any symptoms that would indicate their hip is failing. The FDA has also proposed new regulations that would subject all-metal hips to greater premarket testing, and which also require the manufactures of devices already on the market to conduct safety studies of those products in order to continue selling them.
Recipients of a M2a Magnum hip may be entitled to file their own Biomet hip lawsuit if they experienced serious and debilitating complications allegedly associated with its metal-on-metal design. Find out more about filing a Biomet hip replacement claim by visiting Bernstein Liebhard LLP’s website. To arrange for a free case review, call 800-511-5092 to speak with a member of our legal staff.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP